Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Depression in Type 2 Diabetes

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by University of Illinois at Chicago.
Recruitment status was:  Recruiting
National Institute of Mental Health (NIMH)
Information provided by:
University of Illinois at Chicago Identifier:
First received: March 30, 2011
Last updated: March 31, 2011
Last verified: March 2011
The purpose of the study is to examine the relationship between brain structure and depression in adults aged 30 or older with Diabetes. This relationship is determined using magnetic resonance imaging technology (MRI), a scanner with a magnet that is used to create images of the brain.

Diabetes Mellitus

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Myelin, Glia and Depression in Type 2 Diabetes

Further study details as provided by University of Illinois at Chicago:

Estimated Enrollment: 400
Study Start Date: October 2009
Estimated Study Completion Date: April 2013
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Patients with Major Depressive Disorder
Patients with Type 2 Diabetes
Patients with both diabetes and major depressive disorder
Healthy Controls

  Show Detailed Description


Ages Eligible for Study:   30 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients of all subject types will be recruited through the general medical, psychiatric, and endocrinology clinics associated with the UIC Medical Center. Patients will be first cleared for participation in the study by their primary physicians. The patient and family will be approached by the PI or another investigator who will explain the research and its goals. We also plan to recruit subjects through flyers and advertisements.

Inclusion Criteria:

  • Age: 30 to 80 years old
  • Diagnosis of type 2 diabetes
  • Diagnosis of major depressive disorder using standard diagnostic and statistical manual (DSM) criteria
  • Score of 15 or greater on the 17-item Hamilton Depression rating scale
  • Mini Mental Status Exam score of 24 or greater
  • No evidence of clinical dementia or any other clinical brain disorder
  • Free of psychotropic/psychoactive medications for at least 2 weeks
  • First episode of depression diagnosed either after or around the time type 2 diabetes was diagnosed since we are interested in the relationship between the cerebrovascular effect of diabetes and the pathophysiology of major depression

Exclusion Criteria:

  • Presence of dementia or any other clinical brain disorder (Parkinson's, Alzheimer's)
  • Mini Mental Status Exam score of less than 24
  • Unstable medical illness (grade 4 on the Cumulative Illness Rating Scale)
  • Presence of any metallic implant that would preclude an MRI scan (pacemaker, etc.)
  • Concurrent Axis 1 disorder (schizophrenia, bipolar)
  • Use of atypical neuroleptics for the current episode and/or strong clinical suspicion that the diabetes is secondary to the use of atypical neuroleptics;
  • Recurrent major depression, operationally defined as two or more, well-characterized episodes of depression, prior to the onset/diagnosis of diabetes
  • Seizure disorder
  • Stroke/Transient Ischemic Attack
  • Central nervous system disorder (multiple sclerosis)
  • Trauma to head/Loss of Consciousness
  • Claustrophobia
  • Eating disorder (anorexia, bulimia)
  • Weight of over 350 pounds
  • Learning disorder (dyslexia, ADHD)
  • Psychosis, panic or anxiety disorder outside the context of depression
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01327404

Contact: Monya Meinel, BA, CCRC 312-996-6201

United States, Illinois
University of Illinois Recruiting
Chicago, Illinois, United States, 60612
Contact: Monya Meinel, BA, CCRC    312-996-6201   
Contact: Piotr Daranowski, MA    312-413-8223   
Principal Investigator: Anand Kumar, MD         
Sub-Investigator: Olusola Ajilore, MD, PhD         
Sponsors and Collaborators
University of Illinois at Chicago
National Institute of Mental Health (NIMH)
Principal Investigator: Anand Kumar, MD University of Illinois at Chicago
  More Information

Additional Information:
Responsible Party: Anand Kumar, MD, Head of Psychiatry, University of Illinois Identifier: NCT01327404     History of Changes
Other Study ID Numbers: 2009-0473
5R01MH063764 ( US NIH Grant/Contract Award Number )
Study First Received: March 30, 2011
Last Updated: March 31, 2011

Keywords provided by University of Illinois at Chicago:
Diabetes Mellitus

Additional relevant MeSH terms:
Diabetes Mellitus
Depressive Disorder
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Behavioral Symptoms
Mood Disorders
Mental Disorders processed this record on May 24, 2017